Klarsen specializes in data marketing for customer winning and engagement. Thanks to its qualified data and proprietary technologies, it allows its customers to increase their marketing performance and net sales. Klarsen disposes of proprietary assets and qualified and reactive databases, in its network of partners and on its own.

Employees

Sector

IT Services & Consulting

More about the company

Income Statement and Estimates

More financial data

Real-time BOERSE MUENCHEN Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-100.00%	-100.00%

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Market Cap	2.88M 3.28M 2.65M 2.46M 4.67M 313M 4.73M 31.71M 12.34M 154M 12.33M 12.06M 533M	P/E 2023	3.28x	P/E 2024	-86x
Enterprise Value	3.96M 4.52M 3.64M 3.38M 6.42M 431M 6.51M 43.63M 16.98M 212M 16.97M 16.59M 733M	EV / Sales 2023	1.67x	EV / Sales 2024	0.82x
Free-Float	98.11%	Yield 2023 *	-	Yield 2024	-

11-03	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI
16/10/24	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2024	CI
30/04/24	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/03/24	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
07/11/23	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT
27/10/23	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	CI
28/04/23	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	CI
09/03/23	Acticor Biotech Secures Funding Until November After EUR12 Million Equity Raise; Stock Sinks 17%	MT
23/12/22	Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	MT
14/12/22	Twitter to shut down newsletter product Revue next year	RE
06/12/22	Acticor Biotech Wins EU Health Agency Nod For Phase 2/3 Stroke Study Design	MT
06/10/22	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022	CI

03-03	Klarsen : ALKLA information relative au nombre total de droits de vote et d'actions composant le capital	PU
02-25	Klarsen : ALKLA-Information relative au nombre de droits de vote et actions composant le capital	PU
12-10	Klarsen : ALKLA-Attribution gratuite de BSA	PU
12-09	Klarsen : ALKLA-ACTIVITE 3T2025	PU
11-27	Klarsen : ALKLA-Résultat augmentation de capital	PU

Klarsen Stock BOERSE MUENCHEN

Stocks

4YA

FR0011038348

IT Services & Consulting

Valuation: Klarsen

Latest news : Klarsen

Press Releases: Klarsen

News in other languages: Klarsen

Managers and Directors: Klarsen

Other IT Services & Consulting

Financials

Company Profile

Income Statement and Estimates

07-01	Bourse : Schneider se renforce dans l'IA, Air Liquide investit pour SK Hynix, Nike déçoit
07-01	La Bourse s'habitue à tout
06-30	Klarsen : ALKLA – Point d’information sur la publication des comptes annuels 2025 et la suspension de cotation – 30 Juin 2026
06-09	Klarsen : ALKLA – Report des résultats trimestriels et date de publication des comptes annuels – 9 Juin 2026
06-01	Klarsen : Information réglementée – 2026

Manager	Title	Age	Since
Brice Gazeau CEO	Chief Executive Officer	-	-
Patrice Coffe DFI	Director of Finance/CFO	57	01/07/2008
Jean-Pierre Domingo CTO	Chief Tech/Sci/R&D Officer	-	01/01/2013

Director	Title	Age	Since
Patrice Coffe BRD	Director/Board Member	57	14/06/2010
Gérard Parrou BRD	Director/Board Member	74	27/06/2014
Frédéric Bartoli BRD	Director/Board Member	-	23/03/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLARSEN	-.--%	-100.00%	-	-	1.44M
IBM	+2.50%	+8.18%	+4.01%	+130.32%	282B
SNOWFLAKE INC.	+2.05%	+4.68%	+17.99%	+56.15%	90.84B
ACCENTURE PLC	+3.83%	+14.46%	-52.61%	-53.42%	83.81B
TATA CONSULTANCY SERVICES LTD.	+1.87%	+3.18%	-38.56%	-37.04%	78.05B
RELX PLC	+2.61%	+4.10%	-37.39%	0.00%	56.31B
INFOSYS LIMITED	+2.84%	+7.14%	-34.12%	-19.43%	44.22B
FUJITSU LIMITED	+1.28%	+3.32%	-1.82%	+83.95%	35.79B
NEC CORPORATION	+0.02%	+7.44%	+10.44%	+209.55%	35.52B
HCL TECHNOLOGIES LIMITED	+3.00%	+8.99%	-31.70%	+0.92%	32.17B
Average	+1.99%	+3.78%	-18.20%	+41.22%	82.02B
Weighted average by Cap.	+2.35%	+5.09%	-12.17%	+59.65%

	2023	2024
Net sales	5.03M 5.74M 4.63M 4.3M 8.16M 547M 8.27M 55.41M 21.57M 269M 21.55M 21.08M 932M	6.31M 7.21M 5.81M 5.4M 10.25M 687M 10.38M 69.58M 27.08M 337M 27.06M 26.47M 1.17B
Net income	2.75M 3.14M 2.53M 2.35M 4.47M 300M 4.53M 30.33M 11.8M 147M 11.8M 11.54M 510M	-47.76K -54.54K -43.99K -40.84K -77.55K -5.2M -78.6K -527K -205K -2.55M -205K -200K -8.85M
Net Debt	-634K -724K -584K -542K -1.03M -69.1M -1.04M -7M -2.72M -33.92M -2.72M -2.66M -118M	1.08M 1.23M 995K 924K 1.75M 118M 1.78M 11.92M 4.64M 57.78M 4.63M 4.53M 200M